Burning Rock Biotech (BNR) Research & Development (2020 - 2025)
Historic Research & Development for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to -$5.8 million.
- Burning Rock Biotech's Research & Development rose 1683.32% to -$5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.5 million, marking a year-over-year increase of 2795.08%. This contributed to the annual value of -$31.8 million for FY2024, which is 3488.83% up from last year.
- According to the latest figures from Q3 2025, Burning Rock Biotech's Research & Development is -$5.8 million, which was up 1683.32% from -$6.9 million recorded in Q2 2025.
- In the past 5 years, Burning Rock Biotech's Research & Development registered a high of -$5.6 million during Q1 2025, and its lowest value of -$18.8 million during Q1 2022.
- Its 5-year average for Research & Development is -$11.5 million, with a median of -$11.5 million in 2023.
- As far as peak fluctuations go, Burning Rock Biotech's Research & Development plummeted by 6615.05% in 2021, and later skyrocketed by 3909.62% in 2025.
- Burning Rock Biotech's Research & Development (Quarter) stood at -$17.7 million in 2021, then rose by 17.36% to -$14.6 million in 2022, then rose by 29.55% to -$10.3 million in 2023, then soared by 30.56% to -$7.2 million in 2024, then increased by 18.55% to -$5.8 million in 2025.
- Its Research & Development stands at -$5.8 million for Q3 2025, versus -$6.9 million for Q2 2025 and -$5.6 million for Q1 2025.